Gene transfer with adenoviruses having modified fibre protein
AU3345801A
Recombinase-mediated generation of adenoviral vectors
CA2289215A1
Gene transfer with adenoviruses having modified fiber proteins
US6638762B1
Tissue-vectors specific replication and gene expression
IL127211D0
Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers
AU2677797A
Viral vectors including polynucleotides encoding neurotrophic factors and uses therefor
WO9739776A1
Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents
US5922315A
Adenoviruses having altered hexon proteins
NZ330553A
Recombinase-mediated generation of adenoviral vectors where all adenoviral genes of all regions E1 to E4 and L1 to L5 of the adenoviral genome are eliminated
WO9710007A1
Cancer treatment
WO9636365A1
Gene therapy of hepatocellular carcinoma through cancer-specific gene expression
AU5738996A
Gene therapy through transduction of oral epithelial cells
AU5634696A
Treatment of tumors with cells expressing interferons, tumor necrosis factors, or other cytokines
WO9630051A1
Use of surfactants for introducing genetic material into lung cells
AU5320296A
Modified viral envelope polypeptide
AU4856696A
Delivery of therapeutic agents by gene therapy
CA2206683A1
Improved adenoviral vectors and producer cells
US5998205A
Vectors for tissue-specific replication
WO9617053A1
Vectors for tissue-specific replication
EP0792169A1
Tissue-specific treatment, diagnostic methods, and compositions using replication-deficient vectors
